ZF Commercial Vehicle Solutions India inaugurates ESC test track in Chennai
The Hindu
ZF CVS India inaugurates ESC test track in Chennai for rigorous vehicle stability testing, certified by TUV Rheinland and ARAI.
ZF Commercial Vehicle Solutions (CVS) India inaugurated its state-of-the-art Electronic Stability Control (ESC) test track in Chennai.
The ESC test track provides a controlled environment for rigorous testing of vehicle stability, agility, and handling performance. Certified by TUV Rheinland and ARAI, it is equipped to test a wide range of vehicles, from two-wheelers to heavy commercial vehicles.
The track will also be available for customers and third parties enabling the industry to conduct their own testing at the facility, said the leading global provider of advanced automotive safety systems said in a statement.
“This state-of-the-art facility will enable us to accelerate the development and testing of advanced safety systems, pushing the boundaries of vehicle safety while delivering innovative solutions that save lives. By investing in cutting-edge technology and infrastructure, we continue to stay committed to shaping the future of automotive safety, said its Managing Director P. Kaniappan.
The new facility complements ZF’s existing ABS test track.
RBI Governor Shaktikanta Das admitted to hospital for monitoring, no official information available yet.
Fitch puts Adani Group bonds on watch for downgrade after U.S. bribery charges, impacting financial stability and investments.
Google is fighting to beat back another attack by the U.S. Department of Justice alleging monopolistic conduct in its ad tech.
Meta will face trial in April over the U.S. Federal Trade Commission’s allegations that the social media platform bought Instagram and WhatsApp to crush emerging competition.
HUL shareholders to receive shares in new ice cream business entity, subject to approvals, maximizing value for all.
Vedanta launches $500 million bond issue post-Adani crisis, with Citigroup, JPMorgan, Deutsche Bank declining to comment.
USFDA reports Dr Reddy's and Lupin Pharmaceuticals recalling products in the US due to manufacturing issues.
EPF inoperative accounts rise to ₹8,505.23 crore in 2023-24, EPFO to return funds to beneficiaries, awareness campaigns planned.
S&P Global Ratings revises India's economic growth forecast due to high interest rates and lower fiscal impulse.
Indraprastha Gas Ltd raises CNG prices in select cities, while MGL hikes rates in Mumbai post-elections.
Adani group stocks surge on BSE, NSE; clarifies on Kenya deals amid bribery charges, airport project cancellation.